Zobrazeno 1 - 10
of 24
pro vyhledávání: '"C. Annichiarico"'
Publikováno v:
Annali di Stomatologia, Vol 13, Iss 1-4 (2022)
Over the years, regenerative medicine has been improved thanks to new therapies and new innovative clinical protocols. The purpose of this work was to evaluate the efficacy of Platelet-rich Plasma by retracing the history of the evolution of the prep
Externí odkaz:
https://doaj.org/article/15c8435e4a1547f384224310ee3fc5d7
Autor:
P Lorusso, Giuliano Barsotti, Ilaria Cipollini, Erica Panicucci, Gianfranco Tramonti, Giuliano Mariani, C. Annichiarico
Background: Proteinuria is a risk factor for end-stage renal disease (ESRD). Creatinine clearance (CrCl) is usually used as a marker to monitor the progression of ESRD, while cystatin C (CYST) has also been considered as a marker of renal function. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5afd4ff7ab6fe3bbd750f1c6962807c
http://hdl.handle.net/11568/153539
http://hdl.handle.net/11568/153539
Autor:
C. Annichiarico, M. Norpoth, Marco Ferdeghini, Claudio Bianchi, Romano Bianchi, Carlo Donadio, Gianfranco Tramonti
Publikováno v:
Renal failure. 23(3-4)
Chromogranin A (CGA) is a low MW (49,000) acidic hydrophilic protein. It is synthesized in the chromaffm granules of the neuroendocrine cells, and has been found circulating in the blood of healthy subjects. The aim of this study was to assess the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96afe68ba86dc788961aed846402fd35
https://pubmed.ncbi.nlm.nih.gov/11499560
https://pubmed.ncbi.nlm.nih.gov/11499560
The aim of this study was to evaluate the relationship between renal function and the blood level of some tumor markers that are low molecular weight proteins, that is, tumor-associated trypsin inhibitor (TATI), squamous cells carcinoma antigen (SCC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dd4f63a8d23b9c2cafa7b85ab60dbf9c
http://hdl.handle.net/11562/307215
http://hdl.handle.net/11562/307215
Publikováno v:
Kidney international. Supplement. 63
Tumor-associated trypsin inhibitor (TATI) is a low molecular weight protein employed as tumor marker. To evaluate the role of the kidney in the clearance of TATI we studied the relationship of serum TATI with the glomerular filtration rate (GFR), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6fbce411d6728093161b7570c697a871
https://pubmed.ncbi.nlm.nih.gov/9453997
https://pubmed.ncbi.nlm.nih.gov/9453997
Autor:
M. Norpoth, C. Annichiarico, Marco Ferdeghini, Gianfranco Tramonti, Romano Bianchi, Carlo Donadio, Claudio Bianchi
TATI (tumor associated trypsin inhibitor) is a low molecular weight protein employed as a tumor marker. To evaluate the role of the kidney in the clearance of TATI, we studied the rat kidney uptake of 125I-TATI. Total body scan demonstrated a high ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74022b1c9dcacad94f5eaeb02448f298
http://hdl.handle.net/11562/307484
http://hdl.handle.net/11562/307484
Autor:
Carlo Donadio, Gianfranco Tramonti, M. Norpoth, C. Annichiarico, Romano Bianchi, Claudio Bianchi, Marco Ferdeghini
Tumour-associated trypsin inhibitor (TATI) is a low molecular weight (MW) protein employed as a tumour marker. The blood levels of some low MW proteins increase in renal insufficiency. The aim of this study is to evaluate the relationship between ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501c3470140b8dcb59b1027248f40988
http://hdl.handle.net/11568/176658
http://hdl.handle.net/11568/176658
Autor:
Romano Bianchi, Marco Ferdeghini, Carlo Donadio, Claudio Bianchi, M. Norpoth, Gianfranco Tramonti, C. Annichiarico
Publikováno v:
Nuclear Medicine Communications. 19:501
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd939055f175ef74c917c22f3ff2ff60
https://doi.org/10.1097/00006231-199805000-00045
https://doi.org/10.1097/00006231-199805000-00045
Autor:
Romano Bianchi, Gianfranco Tramonti, Marco Ferdeghini, Claudio Bianchi, C. Annichiarico, Carlo Donadio
Publikováno v:
Nuclear Medicine Communications. 16:402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b33b6d5ba4cd3755d9d27d1c921ba166
https://doi.org/10.1097/00006231-199505000-00029
https://doi.org/10.1097/00006231-199505000-00029
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.